Dose response of a panel of melanoma cell lines to G9, showed that BRAF mutant melanoma cells were sensitive to G9, and the degree of sensitivity correlated with Usp9x and SOX2 expression (Figure 4D). The gene discussed is USP9X; the disease is melanoma.